{
    "2020-11-02": [
        [
            {
                "time": "",
                "original_text": "迈瑞、恒瑞、泰格、石药、华兰生物……上市药企投资价值大PK，你最PICK谁？",
                "features": {
                    "keywords": [
                        "迈瑞",
                        "恒瑞",
                        "泰格",
                        "石药",
                        "华兰生物",
                        "投资价值"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "叮当快药处方药购买机制遭质疑 相比融资俞雷更应关注消费者口碑",
                "features": {
                    "keywords": [
                        "叮当快药",
                        "处方药",
                        "购买机制",
                        "消费者口碑"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药电商"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "可转债周报：重回主线",
                "features": {
                    "keywords": [
                        "可转债",
                        "周报",
                        "主线"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "连锁药店扎堆上市，中小连锁未来生存更艰难！",
                "features": {
                    "keywords": [
                        "连锁药店",
                        "上市",
                        "中小连锁",
                        "生存"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药零售"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "今年医药电商增速或超90%，市场逼近千亿！",
                "features": {
                    "keywords": [
                        "医药电商",
                        "增速",
                        "市场"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药电商"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "【国信医药】上海医药：研发加码持续，创新开花可期（三季报点评）",
                "features": {
                    "keywords": [
                        "上海医药",
                        "研发",
                        "创新",
                        "三季报"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "大参林加速扩张门店增至5541家 前三季度盈利8.67亿远超同行",
                "features": {
                    "keywords": [
                        "大参林",
                        "扩张",
                        "门店",
                        "盈利"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药零售"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "关联交易埋雷 业务偏安一隅：漱玉平民并购扩张再战IPO",
                "features": {
                    "keywords": [
                        "关联交易",
                        "漱玉平民",
                        "并购",
                        "扩张",
                        "IPO"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药零售"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "疫情影响逐渐消退，关注高成长龙头+细分冠军——医药生物上市公司2020年三季报小结",
                "features": {
                    "keywords": [
                        "疫情",
                        "影响",
                        "高成长龙头",
                        "细分冠军",
                        "三季报"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}